Related references
Note: Only part of the references are listed.Machine learning enhances prediction of illness course: a longitudinal study in eating disorders
Ann F. Haynos et al.
PSYCHOLOGICAL MEDICINE (2021)
Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?
Amar D. E. Van Laar et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2021)
The metabolic-epigenetic nexus in type 2 diabetes mellitus
Gareth W. Davison et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Adolescent metabolic syndrome and its components associations with incidence of type 2 diabetes in early adulthood: Tehran lipid and glucose study
Golaleh Asghari et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
The Risk of Type 2 Diabetes Mellitus in a Russian Population Cohort According to Data from the HAPIEE Project
Svetlana V. Mustafina et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Impact of dietary carbohydrate type and protein-carbohydrate interaction on metabolic health
Jibran A. Wali et al.
NATURE METABOLISM (2021)
Emerging roles of β-cell mitochondria in type-2-diabetes
Guy Las et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
SciPy 1.0: fundamental algorithms for scientific computing in Python
Pauli Virtanen et al.
NATURE METHODS (2020)
Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population
Lei Feng et al.
BMJ OPEN (2020)
Improving the accuracy of medical diagnosis with causal machine learning
Jonathan G. Richens et al.
NATURE COMMUNICATIONS (2020)
Feature selection strategies for drug sensitivity prediction
Krzysztof Koras et al.
Scientific Reports (2020)
A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study
Yu Yu et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Serum lipid and lipoprotein levels of middle-aged and elderly Chinese men and women in Shandong Province
Meijian Wang et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study
Jessica Ares et al.
PLOS ONE (2019)
Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults
Sang-Wook Yi et al.
SCIENTIFIC REPORTS (2019)
Review of Machine Learning Algorithms for Diagnosing Mental Illness
Gyeongcheol Cho et al.
PSYCHIATRY INVESTIGATION (2019)
Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination
Alvaro Hernaez et al.
PLOS ONE (2019)
Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years
Meredith S. Duncan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
2018 Guidelines for the management of dyslipidemia
Fun-Jung Rhee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2019)
Machine Learning Methods as a Tool for Predicting Risk of Illness Applying Next-Generation Sequencing Data
Patrick Murigu Kamau Njage et al.
RISK ANALYSIS (2019)
The integrative biology of type 2 diabetes
Michael Roden et al.
NATURE (2019)
Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes
Yoon S. Oh et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Association between insulin resistance and the development of cardiovascular disease
Valeska Ormazabal et al.
CARDIOVASCULAR DIABETOLOGY (2018)
β-Cell Failure or β-Cell Abuse?
Karol Erion et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
Marek Femlak et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Analysis of blood glucose distribution characteristics in a health examination population in Chengdu (2007-2015)
Wenxia Huang et al.
MEDICINE (2017)
Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects
Andrea Natali et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study
Sang-Wook Yi et al.
SCIENTIFIC REPORTS (2017)
Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromso Study 1979-2016
Laila Arnesdatter Hopstock et al.
BMJ OPEN (2017)
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman T. Samuel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010
Philippe Tuppin et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
Fat Depots, Free Fatty Acids, and Dyslipidemia
Jon O. Ebbert et al.
NUTRIENTS (2013)
The toxic truth about sugar
Robert H. Lustig et al.
NATURE (2012)
Mining electronic health records: towards better research applications and clinical care
Peter B. Jensen et al.
NATURE REVIEWS GENETICS (2012)
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
Billie Pettersson et al.
BMC PUBLIC HEALTH (2010)
Fructose: Metabolic, Hedonic, and Societal Parallels with Ethanol
Robert H. Lustig
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2010)
Ten-Year All-Cause Mortality in Presumably Healthy Subjects on Lipid-Lowering Drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort)
Virginie Gardette et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Lipid therapy utilization rates in a managed-care mixed dyslipidemia population
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome
James B. Meigs et al.
DIABETES CARE (2007)
Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study
CM Schubert et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Diabetic dyslipidaemia
Martin Adiels et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Type 2 diabetes as a lipid disorder
MR Taskinen
CURRENT MOLECULAR MEDICINE (2005)
Lipid-lowering therapy with statins in high-risk elderly patients - The treatment-risk paradox
DT Ko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Fatty acid metabolism and insulin secretion in pancreatic beta cells
GC Yaney et al.
DIABETOLOGIA (2003)
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen
DIABETOLOGIA (2003)
Diabetes: mellitus or lipidus?
E Shafrir et al.
DIABETOLOGIA (2003)
Assessing insulin secretion by modeling in multiple-meal tests - Role of potentiation
A Mari et al.
DIABETES (2002)
Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
JD McGarry
DIABETES (2002)
Carbohydrate metabolism in the elderly
D Elahi et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2000)
Share Paper
